|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.38 USD | +0.88% |
|
-1.24% | +67.17% |
| 14/05 | Aspen Aerogels Insider Sold Shares Worth $536,895, According to a Recent SEC Filing | MT |
| 14/05 | Piper Sandler Adjusts Price Target on Aspen Aerogels to $30 From $29, Maintains Overweight Rating | MT |
Aspen Aerogels, Inc. revised earnings guidance for the full year 2024. For the year, the company revised revenue to be greater than $380 million compared to prior guidance of greater than $350 million. Net income to be greater than $2 million against prior guidance of Net loss of greater than $23 million.
Earnings per share to be greater than 0.03 against prior guidance of loss per share of greater than 0.30.
| 1st Jan change | Capi. | |
|---|---|---|
| +67.17% | 199.16Cr | |
| +17.29% | 6.65TCr | |
| +2.81% | 5.03TCr | |
| +17.88% | 4.2TCr | |
| +21.13% | 2.67TCr | |
| +11.82% | 2TCr | |
| +0.19% | 1.73TCr | |
| -21.87% | 1.57TCr | |
| +0.91% | 1.55TCr | |
| -10.58% | 1.5TCr |
ASPEN AEROGELS, INC. 
